bpc-157 gut healing 90 days on - after food poisoning and mold exposure How BPC-157 Peptide Therapy Supports

Real-World Evidence A study published in JAMA Internal Medicine analyzed 18,386 adults who are overweight or with obesity in real-world clinical settings

The peptide is considered a non-approved compound that may enhance performance or recovery, making it restricted for athletes

Therapeutic Research Protocol Dose: 1000 mcg / 1 mg (2 capsules) Duration: 6 8 weeks Frequency: 1 capsule twice daily, morning and evening Cycle Interval: 4 weeks off before repeating Goal / Description: Higher-dose oral regimen evaluated in models targeting tendon, ligament, and gut barrier repair

Degraded GHK-Cu = less active peptide than the label suggests